137 related articles for article (PubMed ID: 23057631)
1. Aberrant drug-related behaviors: unsystematic documentation does not identify prescription drug use disorder.
Meltzer EC; Rybin D; Meshesha LZ; Saitz R; Samet JH; Rubens SL; Liebschutz JM
Pain Med; 2012 Nov; 13(11):1436-43. PubMed ID: 23057631
[TBL] [Abstract][Full Text] [Related]
2. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.
Liebschutz JM; Saitz R; Weiss RD; Averbuch T; Schwartz S; Meltzer EC; Claggett-Borne E; Cabral H; Samet JH
J Pain; 2010 Nov; 11(11):1047-55. PubMed ID: 20338815
[TBL] [Abstract][Full Text] [Related]
3. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
4. The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain.
Park TW; Saitz R; Nelson KP; Xuan Z; Liebschutz JM; Lasser KE
Subst Abus; 2016; 37(4):516-520. PubMed ID: 27092738
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically.
Bouvier BA; Waye KM; Elston B; Hadland SE; Green TC; Marshall BDL
Drug Alcohol Depend; 2018 Feb; 183():73-77. PubMed ID: 29241103
[TBL] [Abstract][Full Text] [Related]
6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
7. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.
Fleming MF; Davis J; Passik SD
Pain Med; 2008 Nov; 9(8):1098-106. PubMed ID: 18721174
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
[TBL] [Abstract][Full Text] [Related]
9. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
[TBL] [Abstract][Full Text] [Related]
10. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Opioid and Benzodiazepine Prescriptions for Osteoarthritis.
Alamanda VK; Wally MK; Seymour RB; Springer BD; Hsu JR;
Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1081-1086. PubMed ID: 31127868
[TBL] [Abstract][Full Text] [Related]
12. Aberrant drug-related behaviors: a qualitative analysis of medical record documentation in patients referred to an HIV/chronic pain clinic.
Merlin JS; Turan JM; Herbey I; Westfall AO; Starrels JL; Kertesz SG; Saag MS; Ritchie CS
Pain Med; 2014 Oct; 15(10):1724-33. PubMed ID: 25138608
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory.
McClure FL; Niles JK; Kaufman HW; Gudin J
J Addict Med; 2017; 11(6):420-426. PubMed ID: 28953504
[TBL] [Abstract][Full Text] [Related]
14. Patient aberrant drug taking behaviors in a large family medicine residency program: a retrospective chart review of screening practices, incidence, and predictors.
Lewis M; Herndon CM; Chibnall JT
J Opioid Manag; 2014; 10(3):169-75. PubMed ID: 24944067
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation.
Palumbo SA; Adamson KM; Krishnamurthy S; Manoharan S; Beiler D; Seiwell A; Young C; Metpally R; Crist RC; Doyle GA; Ferraro TN; Li M; Berrettini WH; Robishaw JD; Troiani V
JAMA Netw Open; 2020 Sep; 3(9):e2015909. PubMed ID: 32886123
[TBL] [Abstract][Full Text] [Related]
16. Correlates of Non-Medical Prescription Drug Misuse Among a Treatment-Seeking Population: A Comparison with Illicit Drug Users.
Pv A; Abdin E; Jun Wen T; Subramaniam M; Cheok C; Song G
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30208591
[TBL] [Abstract][Full Text] [Related]
17. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals.
Hansen L; Penko J; Guzman D; Bangsberg DR; Miaskowski C; Kushel MB
J Pain Symptom Manage; 2011 Dec; 42(6):893-902. PubMed ID: 21802896
[TBL] [Abstract][Full Text] [Related]
18. Past-year use of prescription opioids and/or benzodiazepines among adults in the United States: Estimating medical and nonmedical use in 2015-2016.
Li C; Santaella-Tenorio J; Mauro PM; Martins SS
Drug Alcohol Depend; 2019 Nov; 204():107458. PubMed ID: 31494445
[TBL] [Abstract][Full Text] [Related]
19. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy.
Campbell CI; Kline-Simon AH; Von Korff M; Saunders KW; Weisner C
Subst Use Misuse; 2017 Aug; 52(10):1283-1291. PubMed ID: 28346056
[TBL] [Abstract][Full Text] [Related]
20. Correlates of Benzodiazepine Use and Adverse Outcomes Among Patients with Chronic Pain Prescribed Long-term Opioid Therapy.
Yarborough BJH; Stumbo SP; Stoneburner A; Smith N; Dobscha SK; Deyo RA; Morasco BJ
Pain Med; 2019 Jun; 20(6):1148-1155. PubMed ID: 30204893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
